Ruth Wiley
Obstetrics & Gynecology · Fort Worth, TXNPI 1285810291
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,724 of the $5,060 with a category attached, or 73.6%. It is spread thinly across 38 manufacturers, the largest accounting for just 23.7%.
Across 207 payments — averaging $24.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$1K
- AbbVie$1K
- Exeltis, USA Inc.$312
- Astellas Pharma US Inc$260
- Mayne Pharma Commercial LLC$236
- Avion Pharmaceuticals$144
- plus $2K from 32 others
What the payments were for
- Consulting fees$1,20024%
- Food & beverage$3,72474%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 6 | $1,200 |
| AbbVie(2 entities) | 67 | $1,137 |
| Exeltis, USA Inc. | 17 | $312 |
| Astellas Pharma US Inc | 11 | $260 |
| Mayne Pharma Commercial LLC | 10 | $236 |
| Avion Pharmaceuticals | 9 | $144 |
| Evofem Biosciences, Inc. | 11 | $136 |
| Organon | 9 | $127 |
| Nevro Corp. | 3 | $118 |
| Therapeuticsmd, Inc. | 7 | $114 |
| Covidien LP | 1 | $109 |
| Daiichi Sankyo Inc. | 5 | $108 |
| Portola Pharmaceuticals, LLC | 1 | $108 |
| Millicent US Inc | 5 | $98 |
| Agile Therapeutics, Inc. | 6 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Hologic Sales And Service, LLC | 1 | $66 |
| Aspira Women's Health Inc | 1 | $64 |
| Bayer | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Mylan Pharmaceuticals Inc. | 3 | $47 |
| AMAG Pharmaceuticals, Inc. | 3 | $42 |
| Meditrina | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Minerva Surgical, Inc | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Coopersurgical, Inc. | 2 | $27 |
| Smith+Nephew | 1 | $24 |
| Novum Pharma, LLC | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $18 |
| Merck | 1 | $18 |
| Lupin Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Biogen | 1 | $15 |
| Mission Pharmacal Company | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,060 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $177 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Worth
- David MorelandFort Worth$63K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.